No blood clot reports from Sisonke vaccine trial study

No blood clot reports from Sisonke vaccine trial study - Sahpra
Government announced earlier this week that it had put a temporary hold on the vaccine implementation study following six reported cases of rare blood clots in women who received the Johnson & Johnson vaccine in the United States.
FILE: Nurse Zoliswa Gidi-Dyosi was the first person in South Africa to receive the Johnson & Johnson COVID-19 vaccine on Wednesday, 17 February 2021. Picture: Siya Duda.
4 hours ago
CAPE TOWN - The South African Health Products Regulatory Authority (Sahpra) said that there were no major safety concerns arising from data submitted by Sisonke researchers.

Related Keywords

South Africa , United States , Americans , South African , Kevin Brandt , Boitumelo Semete Makokotlela , Azoliswa Gidi Dyosi , Johnson , Siya Duda , African Health Products Regulatory Authority Sahpra , Nurse Zoliswa Gidi Dyosi , Corona Virus , Covid 19 , Oronavirus In South Africa , South African Health Products Regulatory Authority Sahpra , Sisonke Implementation Study , Ocal , ஒன்றுபட்டது மாநிலங்களில் , அமெரிக்கர்கள் , கெவின் பிராண்ட் , ஜான்சன் , சியா டுடா , கொரோனா வைரஸ் , விட் ,